文献速递眼底病与葡萄膜炎

人工智能评估的维持期积液波动影响多中心常规临床护理国家年龄相关性黄斑变性数据库中抗血管内皮生长因子的视力结局

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.
PubMed 文献 · Br J Ophthalmol · 2025-09-23

该多中心国家队列纳入452只未治疗的新生血管性年龄相关性黄斑变性眼,用人工智能量化光学相干断层扫描中的积液体积波动,发现维持期视网膜内积液、色素上皮脱离、总积液和中心子区厚度的高波动组(Q4)较低波动组(Q1)在3-12个月视力变化更差,部分指标在24个月仍有差异,且注射次数更多。

要点

  • 视网膜内积液、色素上皮脱离、总积液和中心子区厚度波动最高组(Q4)较低波动组(Q1)3-12个月视力变化显著更差。
  • 色素上皮脱离和中心子区厚度波动在24个月时高波动组(Q4)视力变化仍显著更差。
  • 视网膜内积液、视网膜下积液和总积液波动最高组(Q4)3-24个月注射次数中位数显著高于最低组(Q1)。

核心结论

  • 该多中心研究报道维持期特定积液腔隙的积液体积波动对视力结局有负面影响,提示解剖和功能治疗反应模式可能具有积液特异性。

研究设计与样本

  • 多中心、全国性、真实世界队列研究,纳入452只未治疗的新生血管性年龄相关性黄斑变性眼。
  • 使用Fight Retinal Blindness工具收集人口学、视力和注射次数,使用RetinAI Discovery工具量化视网膜内积液、视网膜下积液、色素上皮脱离、总积液和中心子区厚度。
  • 波动定义为眼内量化值的标准差,并按每种生物标志物的标准差四分位数分配眼。

主要发现

  • 3-12个月视力变化:视网膜内积液最高波动组(Q4)-3.91字母 vs 最低波动组(Q1)3.50字母;色素上皮脱离Q4 -4.66 vs Q1 3.29;总积液Q4 -2.07 vs Q1 2.97;中心子区厚度Q4 -1.85 vs Q1 2.96(均p<0.05)。
  • 3-12个月视网膜下积液Q4 0.66 vs Q1 0.93(p=0.91),无显著差异。
  • 24个月视力变化:色素上皮脱离Q4 -8.41 vs Q1 4.98(p<0.05);总积液Q4 -7.38 vs Q1 1.89(p=0.07);中心子区厚度Q4 -10.58 vs Q1 3.60(p<0.05)。
  • 3-24个月注射次数中位数:视网膜内积液Q4 9 vs Q1 8;视网膜下积液Q4 10 vs Q1 8;总积液Q4 10 vs Q1 8(均p<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate the impact of fluid volume fluctuations quantified with artificial intelligence in optical coherence tomography scans during the maintenance phase and visual outcomes at 12 and 24 months in a real-world, multicentre, national cohort of treatment-naïve neovascular age-related macular degeneration (nAMD) eyes. METHODS: Demographics, visual acuity (VA) and number of injections were collected using the Fight Retinal Blindness tool. Intraretinal fluid (IRF), subretinal fluid (SRF), pigment epithelial detachment (PED), total fluid (TF) and central subfield thickness (CST) were quantified using the RetinAI Discovery tool. Fluctuations were defined as the SD of within-eye quantified values, and eyes were distributed according to SD quartiles for each biomarker. RESULTS: A total of 452 naïve nAMD eyes were included. Eyes with highest (Q4) versus lowest (Q1) fluid fluctuations showed significantly worse VA change (months 3-12) in IRF -3.91 versus 3.50 letters, PED -4.66 versus 3.29, TF -2.07 versus 2.97 and CST -1.85 versus 2.96 (all p<0.05), but not for SRF 0.66 versus 0.93 (p=0.91). Similar VA outcomes were observed at month 24 for PED -8.41 versus 4.98 (p<0.05), TF -7.38 versus 1.89 (p=0.07) and CST -10.58 versus 3.60 (p<0.05). The median number of injections (months 3-24) was significantly higher in Q4 versus Q1 eyes in IRF 9 versus 8, SRF 10 versus 8 and TF 10 versus 8 (all p<0.05). CONCLUSION: This multicentre study reports a negative effect in VA outcomes of fluid volume fluctuations during the maintenance phase in specific fluid compartments, suggesting that anatomical and functional treatment response patterns may be fluid-specific.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Martin-Pinardel R, Izquierdo-Serra J, Bernal-Morales C, et al. Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database. Br J Ophthalmol. 2025. PMID: 39848699. doi:10.1136/bjo-2024-325615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。